OMNISCIENCE

This project is handled by OMNISCIENCE

Impacts (know more) :
EN ROUTE VERS UNE REVOLUTION DE LA RECHERCHE CLINIQUE AVEC OMNISCIENCE !

/ Return on investment /

0 % of the project revenue for 5 years.
I.e. in total 0(gross) according to to the project owner’s forecast:
Targeted return on investment:
x... your initial investment in 5 years (i.e. + ... %)
Risk of losing the entire investment. Maximum return on investment: x3,86.
* Tax: Flat tax of 30% on the profit if you declare your income in France. Otherwise, your local tax law applies.

/ Presentation /

project

Pitch

OMNISCIENCE est une SAS (Société par actions simplifiée) créée en 2023 au capital social de 110 300 €. Elle est représentée par Grégory ABERI-MOSKA qui détient 76,7 % des parts de l’entreprise.

impacts

Positive impacts

strategy

Strategy

 

model

Financial data

Target profitability
x3,86 en 5 ans (+286,00 % raw)
Risk of full loss of investment, maximum gain: x3,86
Minimum gain as long as the company is in business: x1,15
Risk
Low risk
rated at 2.47/5 by Internet users during the evaluation phase
Royalties paid quarterly
10,00 % maximum
% of turnover paid to all investors, for 500 000,00 € raised, proportional to the amount raised

Revenues and funding project


We have already gathered 0,00 €

Over the 12 months preceding the fundraising, we achieved 0,00 € in turnover.

Year 1 Year 2 Year 3 Year 4 Year 5
Number of sales 112 680 1500 7100 14200
Projected revenue 560 000,00 € 3 400 000,00 € 7 500 000,00 € 35 500 000,00 € 71 000 000,00 €

Your investment

By investing, you subscribe to OMNISCIENCE for a royalty on the company's turnover, proportional to your investment. The total investors will receive 10,00 % from the turnover achieved each year for a fundraising of 500 000,00 €.
If OMNISCIENCE realizes its forecast, the return for each investor will be 286,00 % gross to 5 years.
Calculate my return

What happens if the forecast is not reached?
In the event that the forecast is not reached after 5 years and the activity continues, OMNISCIENCE will continue to pay the royalties until a return of 1,15 times the amount invested is reached.

When do payments start?
The Royalty is transferred over a period of 5 years from 01/10/2024 and will be paid to investors on a quarterly basis.

All these elements will appear in your contract during the investment.

See the standard contract
This contract is a model, it does not serve as a real contract.

Provisional payment schedule

Attention: these figures are based on an estimate of our turnover. It's up to you to evaluate the forecast and the strategy to estimate whether you can expect to earn more or less than the announced annual return.

Estimated compensation on income of: Date of payment
2024
October, November, December 15/01/2025
2025
January, February, March 15/04/2025
April, May, June 15/07/2025
July, August, September 15/10/2025
October, November, December 15/01/2026
2026
January, February, March 15/04/2026
April, May, June 15/07/2026
July, August, September 15/10/2026
October, November, December 15/01/2027
2027
January, February, March 15/04/2027
April, May, June 15/07/2027
July, August, September 15/10/2027
October, November, December 15/01/2028
2028
January, February, March 15/04/2028
April, May, June 15/07/2028
July, August, September 15/10/2028
October, November, December 15/01/2029
2029
January, February, March 15/04/2029
April, May, June 15/07/2029
July, August, September 15/10/2029

Risk factors

Key risk factors related to the activity and project


Risk related to the financial situation of the company
Currently, prior to the completion of the fundraising of this offer, the company Has, with sufficient net working capital to meet its obligations and cash flow needs for the next 6 months.

Sources of funding under consideration in connection with the project presented for the next 6 months:

Subvention : French Tech Tremplin, Bourse French Tech, CE2i

Concours : CIC Award, Projet Innovation (France 2030 - Hauts-de-France), Concours I-Nov, Fundtruk (sowefund), Trophée Start-up Numérique.

Prêt d'honneur: Hodefi

Prêt bancaire ( Banque privée/BPI)

Avances remboursable (Incubateur/BPI)

Pénétration d'un concurrent sur le territoire national/Européen :

- On lève des fonds pour accélérer l'acquisition des centres hospitalier

- Créer une communauté autour de notre outils (expérience client ++)

No.B.: over time, new risks may emerge and those presented may evolve.

To receive our detailed business plan, contact us at contact@omniscience.cloud

team

Team

stats

Statistics

The project evaluation and investment statistics

Evaluations signe plus

Investments signe plus

/ News /

No news at the moment.

/ Comments /

Vous devez être connecté(e) pour lire et poster des commentaires.

Register Connexion
Our website WEDOGOOD.co and our provider Hubspot use cookies. These allow you to use the online chat, and quickly access the support center. You can choose to accept them or refuse them.